This article was originally published in Start Up
OrthoSensor Inc. has combined electronics, communications and orthopedics technology to enable an array of intelligent orthopedic devices to assist in placement and postoperative monitoring of implants and patients’ musculoskeletal health. This enhanced accuracy and versatility should help health care providers deliver evidence-based medicine that can lead to improved quality and coordination of care. OrthoSensor thinks its technology platform will be applicable to virtually all areas of musculoskeletal disease.
You may also be interested in...
A preview of the emerging health care companies profiled in the current issue of Start-Up. "As Drug-Resistant Microbes Rise, Antibiotic Start-Ups Need Savvy Investors," features profiles of Cempra Pharmaceuticals, DesignMedix, Kenta Biotech and MGB Biopharmaceuticals. Plus these Start-Ups Across Health Care: CardioPhotonics, Eureka Genomics, Invuity and OrthoSensor.
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.